MedTrace Logo

Low Doses Amitriptyline & Chronic Neck Pain

NCT01561209 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2017-08-29

No results posted yet for this study

Summary

The objective of this prospective randomized and controlled study is to evaluate the efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck pain.

Conditions

  • Neck Pain

Interventions

DRUG

Amitryptiline

Amitryptiline 5 mg before bedtime for 2 months

DRUG

Placebo

Placebo pill 1 before bedtime

Sponsors & Collaborators

  • St Joseph University, Beirut, Lebanon

    lead OTHER

Principal Investigators

  • Joseph Maarrawi, MD, PhD · St Joseph University, Beirut, Lebanon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01561209 on ClinicalTrials.gov